Journal article 492 views 144 downloads
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics
Gianmarco Abbadessa
,
Ai Nagano,
Simon Hametner,
Owain Howell
,
David Owen,
Artemis Papadaki
,
Prashant Srivastava,
Simona Bonavita,
Roberta Magliozzi
,
Richard Reynolds,
Mie Rizig,
Richard Nicholas
Annals of Neurology
Swansea University Author:
Owain Howell
-
PDF | Version of Record
© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License.
Download (7.81MB)
DOI (Published version): 10.1002/ana.27216
Abstract
ObjectivesRapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative m...
| Published in: | Annals of Neurology |
|---|---|
| ISSN: | 0364-5134 1531-8249 |
| Published: |
Wiley
2025
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa68903 |
| first_indexed |
2025-02-17T16:02:05Z |
|---|---|
| last_indexed |
2025-03-26T05:31:08Z |
| id |
cronfa68903 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2025-03-25T15:04:35.2052539</datestamp><bib-version>v2</bib-version><id>68903</id><entry>2025-02-17</entry><title>Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics</title><swanseaauthors><author><sid>58c995486fc93a242b987640b692db8c</sid><ORCID>0000-0003-2157-9157</ORCID><firstname>Owain</firstname><surname>Howell</surname><name>Owain Howell</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-02-17</date><deptcode>MEDS</deptcode><abstract>ObjectivesRapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative methods are essential for accurately understanding the molecular mechanisms underlying MS pathology.MethodsWe conducted a gene prioritization analysis of MS white matter pathology transcriptomic studies. Articles were sought in Scopus and PubMed up to July 31, 2024. Potentially eligible publications were those that provided either transcriptomics datasets (deposited in GEO) or lists of differentially expressed genes comparing MS white matter to control white matter.ResultsApplying a vote-count strategy to search for the intersection of genes reported in multiple independent studies with a consistent fold-change direction, followed by a Monte Carlo simulation, we identified 528 highly significant differentially expressed multi-study genes (p < 0.0001; 10,000 simulations). Functional enrichment analysis revealed deregulation of the folate pathway in MS normal-appearing white matter, and tumor necrosis factor (TNF) -related and complement-related pathways in active and chronic active lesions, respectively. Network analysis identified 6 key signaling hubs: PTPRC, HLA-B, MYC, MMP2, COL11A2, MAG. The major nodes identified revealed mechanistic concordance with published in vivo MS models, supporting their value as potential therapeutic targets.InterpretationOur strategy provides a robust framework for integrating gene expression data, effectively identifying the intricate pathways altered in human diseased tissues. This method holds potential for translating findings into drug development strategies. ANN NEUROL 2025</abstract><type>Journal Article</type><journal>Annals of Neurology</journal><volume>0</volume><journalNumber/><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0364-5134</issnPrint><issnElectronic>1531-8249</issnElectronic><keywords/><publishedDay>14</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2025</publishedYear><publishedDate>2025-02-14</publishedDate><doi>10.1002/ana.27216</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>G.A. was supported by the European Academy of Neurology (EAN) Research Fellowship 2024.</funders><projectreference/><lastEdited>2025-03-25T15:04:35.2052539</lastEdited><Created>2025-02-17T14:35:23.0692934</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Gianmarco</firstname><surname>Abbadessa</surname><orcid>0000-0001-8912-3055</orcid><order>1</order></author><author><firstname>Ai</firstname><surname>Nagano</surname><order>2</order></author><author><firstname>Simon</firstname><surname>Hametner</surname><order>3</order></author><author><firstname>Owain</firstname><surname>Howell</surname><orcid>0000-0003-2157-9157</orcid><order>4</order></author><author><firstname>David</firstname><surname>Owen</surname><order>5</order></author><author><firstname>Artemis</firstname><surname>Papadaki</surname><orcid>0000-0002-2295-3713</orcid><order>6</order></author><author><firstname>Prashant</firstname><surname>Srivastava</surname><order>7</order></author><author><firstname>Simona</firstname><surname>Bonavita</surname><order>8</order></author><author><firstname>Roberta</firstname><surname>Magliozzi</surname><orcid>0000-0001-8284-7763</orcid><order>9</order></author><author><firstname>Richard</firstname><surname>Reynolds</surname><order>10</order></author><author><firstname>Mie</firstname><surname>Rizig</surname><order>11</order></author><author><firstname>Richard</firstname><surname>Nicholas</surname><orcid>0000-0003-0414-1225</orcid><order>12</order></author></authors><documents><document><filename>68903__33880__0addfaf66253435a8024f85da14e565a.pdf</filename><originalFilename>68903.VoR.pdf</originalFilename><uploaded>2025-03-25T14:19:00.1279967</uploaded><type>Output</type><contentLength>8190050</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
| spelling |
2025-03-25T15:04:35.2052539 v2 68903 2025-02-17 Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 58c995486fc93a242b987640b692db8c 0000-0003-2157-9157 Owain Howell Owain Howell true false 2025-02-17 MEDS ObjectivesRapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative methods are essential for accurately understanding the molecular mechanisms underlying MS pathology.MethodsWe conducted a gene prioritization analysis of MS white matter pathology transcriptomic studies. Articles were sought in Scopus and PubMed up to July 31, 2024. Potentially eligible publications were those that provided either transcriptomics datasets (deposited in GEO) or lists of differentially expressed genes comparing MS white matter to control white matter.ResultsApplying a vote-count strategy to search for the intersection of genes reported in multiple independent studies with a consistent fold-change direction, followed by a Monte Carlo simulation, we identified 528 highly significant differentially expressed multi-study genes (p < 0.0001; 10,000 simulations). Functional enrichment analysis revealed deregulation of the folate pathway in MS normal-appearing white matter, and tumor necrosis factor (TNF) -related and complement-related pathways in active and chronic active lesions, respectively. Network analysis identified 6 key signaling hubs: PTPRC, HLA-B, MYC, MMP2, COL11A2, MAG. The major nodes identified revealed mechanistic concordance with published in vivo MS models, supporting their value as potential therapeutic targets.InterpretationOur strategy provides a robust framework for integrating gene expression data, effectively identifying the intricate pathways altered in human diseased tissues. This method holds potential for translating findings into drug development strategies. ANN NEUROL 2025 Journal Article Annals of Neurology 0 Wiley 0364-5134 1531-8249 14 2 2025 2025-02-14 10.1002/ana.27216 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Another institution paid the OA fee G.A. was supported by the European Academy of Neurology (EAN) Research Fellowship 2024. 2025-03-25T15:04:35.2052539 2025-02-17T14:35:23.0692934 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Gianmarco Abbadessa 0000-0001-8912-3055 1 Ai Nagano 2 Simon Hametner 3 Owain Howell 0000-0003-2157-9157 4 David Owen 5 Artemis Papadaki 0000-0002-2295-3713 6 Prashant Srivastava 7 Simona Bonavita 8 Roberta Magliozzi 0000-0001-8284-7763 9 Richard Reynolds 10 Mie Rizig 11 Richard Nicholas 0000-0003-0414-1225 12 68903__33880__0addfaf66253435a8024f85da14e565a.pdf 68903.VoR.pdf 2025-03-25T14:19:00.1279967 Output 8190050 application/pdf Version of Record true © 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License. true eng http://creativecommons.org/licenses/by/4.0/ |
| title |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| spellingShingle |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics Owain Howell |
| title_short |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| title_full |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| title_fullStr |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| title_full_unstemmed |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| title_sort |
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics |
| author_id_str_mv |
58c995486fc93a242b987640b692db8c |
| author_id_fullname_str_mv |
58c995486fc93a242b987640b692db8c_***_Owain Howell |
| author |
Owain Howell |
| author2 |
Gianmarco Abbadessa Ai Nagano Simon Hametner Owain Howell David Owen Artemis Papadaki Prashant Srivastava Simona Bonavita Roberta Magliozzi Richard Reynolds Mie Rizig Richard Nicholas |
| format |
Journal article |
| container_title |
Annals of Neurology |
| container_volume |
0 |
| publishDate |
2025 |
| institution |
Swansea University |
| issn |
0364-5134 1531-8249 |
| doi_str_mv |
10.1002/ana.27216 |
| publisher |
Wiley |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science |
| document_store_str |
1 |
| active_str |
0 |
| description |
ObjectivesRapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative methods are essential for accurately understanding the molecular mechanisms underlying MS pathology.MethodsWe conducted a gene prioritization analysis of MS white matter pathology transcriptomic studies. Articles were sought in Scopus and PubMed up to July 31, 2024. Potentially eligible publications were those that provided either transcriptomics datasets (deposited in GEO) or lists of differentially expressed genes comparing MS white matter to control white matter.ResultsApplying a vote-count strategy to search for the intersection of genes reported in multiple independent studies with a consistent fold-change direction, followed by a Monte Carlo simulation, we identified 528 highly significant differentially expressed multi-study genes (p < 0.0001; 10,000 simulations). Functional enrichment analysis revealed deregulation of the folate pathway in MS normal-appearing white matter, and tumor necrosis factor (TNF) -related and complement-related pathways in active and chronic active lesions, respectively. Network analysis identified 6 key signaling hubs: PTPRC, HLA-B, MYC, MMP2, COL11A2, MAG. The major nodes identified revealed mechanistic concordance with published in vivo MS models, supporting their value as potential therapeutic targets.InterpretationOur strategy provides a robust framework for integrating gene expression data, effectively identifying the intricate pathways altered in human diseased tissues. This method holds potential for translating findings into drug development strategies. ANN NEUROL 2025 |
| published_date |
2025-02-14T07:32:41Z |
| _version_ |
1850743310463795200 |
| score |
11.088929 |

